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ABSTRACT
PURPOSE We wanted to evaluate novel decision aids designed to help patients
trust and accept the controversial, evidence-based, US Preventive Services Task
Force recommendations about prostate cancer screening (from 2012) and mammography screening for women aged 40 to 49 years (from 2009).
METHODS We created recorded vignettes of physician-patient discussions about

prostate cancer screening and mammography, accompanied by illustrative slides,
based on principles derived from preceding qualitative work and behavioral science literature. We conducted a randomized crossover study with repeated measures with 27 men aged 50 to 74 years and 35 women aged 40 to 49 years. All
participants saw a video intervention and a more traditional, paper-based decision aid intervention in random order. At entry and after seeing each intervention, they were surveyed about screening intentions, perceptions of benefits and
harm, and decisional conflict.
RESULTS Changes in screening intentions were analyzed without regard to order

of intervention after an initial analyses showed no evidence of an order effect.
At baseline, 69% of men and 86% of women reported wanting screening, with
31% and 6%, respectively, unsure. Mean change on a 3-point, yes, unsure, no
scale was –0.93 (P = <.001) for men and –0.50 (P = <.001) for women after
seeing the video interventions vs 0.0 and –0.06 (P = .75) after seeing the print
interventions. At the study end, 33% of men and 49% of women wanted screening, and 11% and 20%, respectively, were unsure.
CONCLUSIONS Our novel, persuasive video interventions significantly changed

the screening intentions of substantial proportions of viewers. Our approach
needs further testing but may provide a model for helping patients to consider
and accept evidence-based, counterintuitive recommendations.
Ann Fam Med 2017;15:48-55. https://doi.org/10.1370/afm.1996.
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atients face many medical decisions, and rarely is the evidence
about the balance of benefits and harms so unequivocal that it can
be assumed all patients would make the same choice if adequately
informed. Evidence can be complicated and incomplete, and experts’ recommendations may conflict. Even when there is an evidence-based recommendation for a specific medical decision, patients’ values might lead to a
different choice. Patients are exposed to social norms, media campaigns,
and powerful anecdotes regarding testing.1,2 Furthermore, human decision
making rarely fits the idealized model of a rational, informed process.3,4
Order of presentation, loss- vs gain-based framing, anchor effects, and
perceived norms can introduce biases,5-10 and adding information can
make decisions more difficult.11-14 Shortcuts (heuristics) used to simplify
decisions often lead to suboptimal choices.15,16
Thus, the ideal of the informed decision is difficult to achieve in practice. Charles et al note, “Patient preferences for information do not neces-
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sarily translate into information seeking behavior; nor
do patients who express preferences for some form
of shared decision making necessarily act on these in
the medical encounter.”17 Patients who may not have
clearly defined values or preferences when asked to
make a decision may, instead, construct a preference
to justify their choice.18 A Cochrane review of decision aids for treatment and screening decisions concluded there was high-quality evidence that decision
aids could improve knowledge and reduce decisional
conflict, moderate-quality evidence for helping people
be more active in making decisions and improving risk
perception, and low-quality evidence that decision aids
led to decisions more congruent with patients’ values.19
For preventive services, the focus has been more
on promoting uptake; for cancer screening tests, the
typical view is that more is better20,21 given the paradigm of early detection increasing chances for a cure.
Few patients understand that some screening tests may
reduce mortality only modestly or can result in harm.22
Little research has focused on helping clinicians and
patients overcome their biases as they present information about screening benefits, harms, and uncertainties
and attempt to make informed and/or shared decisions.23
The United States Preventive Services Task Force’s
(USPSTF) recommendation that women aged 40 to 49
years should make preference-based, individual decisions about mammography highlights the need for the
development of effective, evidence-based approaches
to help patients understand why seemingly counterintuitive recommendations might make sense.24,25 The
USPSTF recommendation against screening for prostate cancer with the prostate specific antigen (PSA)
test26 provides further impetus for such approaches.
Americans receive substantial amounts of low-value
medical care.27-33 When recommending against care
can evoke fear and distrust, clinicians are challenged to
explain why a test or treatment might not be beneficial,
a challenge compounded by advocacy groups mounting campaigns based on strong, emotional messages
rather than unbiased evidence.
Some authors have suggested that advocacy should
be combined with unbiased information, sometimes
described as informed advocacy34 and beneficent persuasion.35 Swindell et al argue that autonomy is not what
patients value most in their medical decision making,
nor do most medical decisions resemble the model of
an informed, autonomous choice.36 Typical medical
practice more closely resembles an advocacy-based
process than informed, shared decision making.
Patients often receive recommendations about
preference-sensitive choices with little or no discussion, and information is presented in an attempt to
persuade only if they offer resistance. When strong,
ANNALS O F FAMILY MEDICINE

✦

persuasive messaging is used to advocate for a specific
choice, patients may need help understanding the
rationale for making a considered decision.
In this article, we present the results of an initial
evaluation of interventions developed to help patients
consider and trust the 2009 USPSTF recommendations that women in their 40s should make an informed
choice about mammography and the 2012 recommendation against prostate cancer screening.

METHODS
Overview and Development of Interventions
This study proceeded in 3 phases; phases 1 and 2
focused on intervention development, and phase 3
tested intervention effectiveness. This report focuses
on phase 3, but begins with a brief overview of the first
2 phases to facilitate understanding of our approach
and interventions.
Phase 1 involved the conduct and qualitative
analyses of 6 focus groups (2 in English and 1 in Spanish with men aged 50 to 74 years discussing prostate
cancer screening and the same with women aged 40 to
49 years discussing mammography). The focus groups
were conducted to help us understand participants’
attitudes toward the cancer screening tests we were
addressing and factors that might lead patients to trust
the USPSTF’s recommendations. We concluded that (1)
discussion needed to begin with information about the
harms and limited efficacy of the tests because, without
that information, considering not being screened did
not make sense; (2) participants were unaware of specific guidelines; (3) discussion of guideline development
processes and potential bias had no impact on participants’ views; (4) participants were not familiar with
the USPSTF, and attempts to distinguish the USPSTF
from other groups using bias-prone processes had no
impact; (5) anecdotal experiences of family and friends
with cancer screening, diagnosis, and treatment were
powerful in shaping views about screening, even if the
anecdotes were not about breast or prostate cancer
screening; and (6) although no participant asked for
evidence supporting cancer screening, many wanted
to know there was good evidence supporting a recommendation to consider not being screened.
In phase 2, we developed sets of 3 videos of
narrated slide presentations for each topic in both
English and Spanish. One was framed as a conversation among friends, including a community health
worker knowledgeable about the topic, 1 portrayed
a physician-patient conversation, and the third was a
presentation by an unseen narrator. The level of detail
about the evidence varied in the presentations, being
least in the first, and greatest in the last. We conducted
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6 additional focus groups, organized as in phase 1, in
which participants viewed the presentations in varying order and discussed their reactions to each. Other
than 1 group of men disliking the friends’ conversation format, there were no strong preferences for
any particular format. Some participants stated that a
physician-patient conversation seemed more convincing, and some stated that hearing the complex information more than once was helpful.
Based on these findings and the current literature on persuasion and behavior change, we then
developed video presentations of slide shows, framed
as physician-patient conversations (mammography,
English, at https://youtu.be/6uGy72OCv_Q; mammography, Spanish, at https://youtu.be/rs_pKyFo1DA;
prostate cancer screening, English, at https://youtu.be/
v5z2Go4ZpO4; prostate cancer screening, Spanish, at
https://youtu.be/nBce9xJo1lc). Overall flow and content
are available in the Supplemental Figure, http://annfammed.org/content/15/1/48/suppl/DC1. Duration of the
video presentations ranged from about 13½ minutes to
almost 23 minutes, with Spanish-language and mammography presentations being longer.
Comparator Interventions
We sought unbiased, evidence-based comparators that
were reasonably consistent with USPSTF recommendations and freely available for public use. For prostate
cancer screening, we chose a composite of 2 paperbased decision aids developed by a multidisciplinary
prostate cancer work group for the Massachusetts
Department of Public Health for dissemination to
primary care clinicians for use with men in Massachusetts.37,38 In a small pilot test, the decision aids were
well received by patients and clinicians. For mammography, we used a paper-based Summary for Patients
from the American College of Physicians that outlined
the 2007 guidelines for mammography screening in
women aged 40 to 49 years.39
Participant Recruitment
Men aged 50 to 74 years without a history of prostate cancer and women aged 40 to 49 years without a
history of breast cancer who spoke English or Spanish were eligible to participate. We recruited a convenience sample using a broad outreach approach,
including mailings to potentially eligible participants
attending primary care clinics identified from hospital
and community health center administrative data, signs
placed in the academic medical center, outreach to
persons who had indicated interest in participating in
research studies to the UMass Center for Clinical and
Translational Science, outreach to community contacts
by study members from the Central Massachusetts
ANNALS O F FAMILY MEDICINE
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Area Health Education Center, and ads posted on
Craigslist. Our goal was to recruit a sample with as
much racial, ethnic, linguistic, and socioeconomic variation as possible with our available resources. Participants were informed they would be paid $40 for up to
2 hours of their time. Interested eligible persons were
scheduled to come in for a study visit with a bilingual
community health worker.
Conduct of Study Sessions
All participants received both interventions. For the
following reasons they were randomly assigned to see
either our video intervention or the printed decision
aid first: (1) comments in our phase 2 focus groups
about the value of hearing the information more than
once made us suspect we might see greater effects
from multiple exposures; (2) as a formative study, we
wanted to compare information from participants
about the 2 types of interventions; and (3) we wanted
to maximize the information we could obtain from
each participant, knowing our resources were limited.
Study data were collected and managed using electronic data capture (REDCap) research tools40 hosted
at the University of Massachusetts Medical School
(UMMS). Randomization was carried out via REDCap
with concealed allocation, stratified by sex and language spoken. Participants responded to survey questions in English or Spanish using a touchscreen tablet
that directly entered the data into REDCap; a community health worker provided assistance as needed.
After answering questions about demographics, family
history, and experience with the screening test, participants were asked to indicate whether they wanted
the test (yes, unsure, no), felt getting the test was right
for them, and expected to discuss screening with their
physician in the coming year (5-point Likert scales from
“definitely yes” to “definitely no”). The low-literacy version of the Decisional Conflict Scale41,42 was used to
measure 4 aspects of decisional conflict—uncertainty,
feeling informed, clarity about personal values, and
feeling supported in making the decision—with higher
scores reflecting greater conflict.41 We also asked them
their opinion on the balance of benefits and harms of
the screening test (based on a 5-point Likert scale)
and to indicate how much the women thought regular
screening reduced a person’s risk of dying of cancer
(less than 25%, 25% to 49%, 50% to 75%, more than
75%, or absolutely no idea). Women were asked how
often a woman should get mammograms once she
started (every 1, 2, or 3 years, or not sure). Participants
were then shown the intervention they had been randomized to see first and asked again to complete the
Decisional Conflict Scale and the questions about their
screening intentions and perceived benefits and harms.
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The community health worker offered to clarify any
issues within their scope of training. Participants were
shown the second intervention and asked to answer
questions including those listed above.
This project was approved by the University of Massachusetts Medical School Institutional Review Board.
Analyses
Statistical analyses were conducted using SAS 9.2 (SAS
Institute, Inc). Nonparametric tests were used to assess
significance of responses to questions with yes, unsure,
no and Likert-scale scores. Changes on the Decisional
Conflict Scale responses were assessed using t tests.
We compared changes in screening attitudes and intentions after seeing each intervention, suspecting from
previous feedback that attitudes might change progressively after seeing each intervention.

RESULTS
As shown in Table 1, 27 men and 35 women participated. Most were non-Hispanic white, and nearly
90% had some education beyond high school. About
one-fourth of women were Spanish-speaking Latinas,
whereas only 1 man was a Spanish-speaking Latino.
As displayed in Figures 1 and 2, preferences for
both prostate cancer screening and mammography
changed significantly after viewing the video presentations but not after viewing the print (control) decision
aid. For men, preferences changed primarily from
wanting to not wanting screening, whereas for women
the change was more balanced between being unsure
Table 1. Participant Demographics
Men
(n = 27)

Women
(n = 35)

58

46

White

85

60

Black

4

3

Asian

0

6

Other, unknowna

11

31

Hispanic ethnicity, %

11

34

Characteristic
Mean age, y

DISCUSSION
Our interventions, designed to help viewers trust and
accept the recommendations from the USPSTF on
prostate cancer screening for men and screening mammography for women aged 40 to 49 years clearly influenced a number of participants to reconsider whether
they wanted screening and changed the reported
preferences of statistically significant proportions of
our participants. This outcome is notably different
from those reported for the use of many decision aids,
including a recently published randomized controlled
trial comparing 4 print formats for presenting information about 3 low-value screening tests, including the
PSA test43; a recent evaluation of a decision aid for
mammography for women in their forties that reported
a significant decrease in decisional conflict, but no
significant change in screening intentions44; and the

Race, %

Education, %
≤High school graduate

12

11

Some college or college graduate

35

49

≥4 Years of college
Previously screened for prostate/breast
cancer, %
Previous abnormal prostate/breast cancer
screening result, %
Previous prostate/breast biopsy, %

54

40

46

91

11

37

4

9

Almost all Hispanic participants left the race options blank, as they did not
identify with race as a construct.
a

ANNALS O F FAMILY MEDICINE

✦

and not wanting screening. Because the order of the
information given had no effect, we presented the
analyses of changes after seeing each type of intervention, ignoring order. We found significant changes in
participants’ desire for both tests, feeling the test was
right for them, and perceptions of the balance of benefits and harms. There was also a smaller, but statistically significant, change in men’s perceptions of the
balance of benefits and harms after viewing the print
comparator (Table 2). Although our interventions were
intended for shared decision making, we found they
resulted in a significant decrease in men’s intentions to
discuss prostate cancer screening with their physicians;
women’s intentions trended in the same direction,
though they were not significant at the P <.05 level.
Desired frequency of mammography screening
also changed after seeing the interventions. At entry,
54% of women reported that women should get annual
mammograms once they started, and 34% indicated
it should be biennial. This frequency changed to
14% annually and 60% biennially after viewing both
interventions. Endorsement of biennial mammograms
increased minimally (6%) after seeing the paper decision aid and more (20%) after our seeing our narrated
video intervention, but this difference was not statistically significant.
Decisional Conflict Scale scores decreased substantially and progressively, and they were also not statistically significantly related to which intervention was
received first. On a scale ranging from 0 (no conflict)
to 100 (maximal conflict), scores for men decreased
from a mean of 57 to 15 after seeing their first intervention and further decreased to a mean of 8 after seeing the second. For women, scores decreased from 32
to 18 to 13, respectively.
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Figure 1. Expressed preferences for prostate-specific antigen testing after seeing video, then paper, or vice versa
(total n = 27 men aged 50-74 years).
No

Unsure

Yes

100
90
80

Percentage

70
60
50
40
30
20
10
0
Baseline
(video
1st group)

After
video

After
paper

Baseline
(paper 1st
group)

After
paper

After
video

Figure 2. Expressed preferences for mammography testing after seeing video, then paper, or vice versa (total
n = 35 women aged 40-49 years).
No

Unsure

Yes

100
90
80

Percentage

70
60
50
40
30
20
10
0
Baseline
(video
1st group)

After
video

After
paper

Cochrane review of decision aids, which found variable effects on choices, including mixed effects for PSA
decision aids.19
We believe there are several reasons why, in our
study, men were more likely than women to change
ANNALS O F FAMILY MEDICINE
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Baseline
(paper 1st
group)

After
paper

After
video

from desiring to rejecting screening and women were
more likely to end up uncertain. Major harms associated with prostate cancer screening (eg, impotence and
incontinence) are easily understood and highly undesirable, whereas some harms associated with mammog-
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Table 2. Changes in Screening Attitudes Toward Cancer Screening
After Printed
(Control) Intervention
Mean Change
(P Value)a

After Video
Intervention
Mean Change
(P Value)a

Video vs Print
Difference
Mean Change
(P Value)a

Want PSA (yes = 2, unsure = 1, no = 0)

0.0 (>.99)

–0.93 (<.001)

–0.88 (<.001)

PSA right for meb

0.0 (>.99)

–1.6 (<.001)

–1.6 (<.001)

–1.9 (<.001)

–1.3 (.007)

–0.44 (.03)

–0.58 (.003)

–0.06 (.75)

–0.50 (<.001)

–0.44 (.01)

0.06 (.82)

–0.77 (<.001)

–0.83 (.002)

–0.14 (.38)

–0.65 (<.001)

–0.50 (.046)

–0.29 (.07)

–0.29 (.17)

Measure
PSA screening

PSA harm-benefit balanceb

–0.53 (.01)

Intend to discuss PSA with physicianb

0.12 (.38)

Mammography screening
Want mammography (yes = 2, unsure = 1, no = 0)
Mammography right for meb
Mammography harm-benefit balanceb
Intend to discuss mammography with physicianb

0.0 (>.99)

PSA = prostate-specific antigen.
Note: Interventions were presented to participants randomly.
a
b

Wilcoxon signed rank tests used to assess significance.
Score based on 5-point Likert scale, where 1= definitely yes, to 5 = definitely no.

raphy are less clear (eg, anxiety) or subtle and poorly
understood (eg, overdiagnosis and overtreatment).
Second, the evidence we presented indicated that prostate cancer screening might provide no benefit, saving 0 to 1 life per 1,000 men screened over 10 years,
whereas mammography evidence indicated a modest
mortality reduction of 1 life saved for every 2,000
women screened over 10 years. Third, our qualitative
work found that women have been heavily socialized
to value mammography, which was uncommon for PSA
screening. Finally, the USPSTF recommendation is
against prostate cancer screening; for mammography
the recommendation is to make an informed choice,
and women accepting the USPSTF’s recommendation
might appropriately end up being uncertain, with fewer
expected to decide against screening.
In developing this project, given the generally limited effects of knowledge on behavior, we had expected
to focus on crafting persuasive messages rather than
offering substantial amounts of the data about the tests.
Our focus group work, however, led us to believe we
needed to present the key data. We found that if we
could get people to consider the USPSTF recommendations, they wanted to know the data were available
on which the recommendations were based, even if it
was hard to understand. For the USPSTF mammography recommendation, where patients are encouraged to
make a personal, informed decision rather than a specific choice, we are unclear what the appropriate next
step should be for those who, understanding the issues,
find themselves uncertain about what to do. Providing
additional resources may help some patients, but finding resources for unbiased, balanced, and sufficiently
complete information is problematic. Choosing what
ANNALS O F FAMILY MEDICINE
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information to present, the order and style of presentation, and the amount of detail is an editorial choice
that reflects the views of the developers. The more
controversial the decision, the more difficult and important such choices will be. Carefully trained navigators
might be able to help uncertain patients make a choice
without injecting bias, but sustainable funding for such
efforts outside a few special cases seems unlikely. Our
findings also highlight that better informed patients
may be less likely to want to share decision making
with their clinicians.
Of note, most women expressed a preference for
biennial rather than annual screening after seeing both
interventions. If such a decision were durable and acted
upon, it would substantially reduce the harms and costs
of mammography with a minimal decrease in benefit.45
We found similarly substantial reductions in decisional conflict with our narrated, persuasive video
interventions and the print decision-aid interventions,
whereas only our video interventions had any effect on
preferences. For mammography, we had hypothesized
that a greater understanding of the issues might lead to
greater decisional conflict, but we did not observe this
outcome. Our findings should lead to careful thought
about the role of decisional conflict in assessing overall
decisional quality, because they suggest that a reduction in decisional conflict may be more reflective of
going through the process of making or confirming a
previous decision than of how well information was
really understood and utilized.
Our study has a number of limitations. First, we
measured a short-term change in attitudes, but we do
not know whether this change will translate into action.
Second, the print interventions we used for compari-
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son cannot be assumed to be representative of all print
decision aids intended to inform but not designed to
be persuasive interventions. We believed it was important to present for comparison nonproprietary decision
aids that did not conflict with the evidence summaries
produced for the USPSTF. Our video interventions differed in many ways from the paper decision aids used
for comparison besides their persuasive aims. The paper
PSA decision aid encouraged making a choice based
on personal values and consulting one’s physician, so
any induced change would be expected to be smaller.
Our narrated video slide shows with a story line were
more engaging than the print presentations. Our video
interventions ran 13 to 23 minutes, substantially longer
than participants spent with the print decision aids
and provided more detailed information, because our
formative work indicated patients wanted to see the evidence when considering the counterintuitive USPSTF
recommendations. It is possible that narrated presentations of similar length and detail but not designed to
encourage viewers to trust and accept a specific recommendation would have had similar effects. Based on our
experiences in phase 1 of this project, we think this is
unlikely. Third, we chose to use the low-literacy version of the Decisional Conflict Scale, because we were
expecting many participants to have limited literacy.
The article describing the low-literacy version of the
Decisional Conflict Scale raised some questions about
distinctness and validity of some subscales, however, so
our findings could be affected by specific characteristics
of the low-literacy Decisional Conflict Scale. Finally,
we tested our interventions with small, convenience
samples of men and women in one city in central Massachusetts. Generalizability of our findings to other
populations needs to be evaluated in future studies.
Given our results, we believe that findings from
our prior qualitative work, along with guidance from
behavioral science and marketing research, led to the
success of our video interventions. If our video intervention findings are replicated in other populations,
they could serve as a template for the development of
persuasive interventions when targeting other controversial recommendations and low-value procedures.
We offer the following points when developing such
interventions:
1. Begin by asking people to think about the key
questions without directly confronting their existing
beliefs to set the stage for reconsideration while minimizing the risk of a defensive response.
2. Follow with describing harms and making
explicit that benefits are smaller than most believe.
3. Offer difficult information more than once, with
increasing detail, to allow viewers to grasp the overall
message before they try to understand the finer details.
ANNALS O F FAMILY MEDICINE
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4. Portray a trusted professional as the source of
information to encourage narrative engagement and
evoke credibility.
A key question is whether interventions such as
ours will lead to changes in behavior. An important
next step is testing such interventions in pragmatic
clinical trials to evaluate them in clinical practice.
We are aware that a persuasive approach is likely to
arouse controversy, because persuasion is sometimes
used to convince people to make choices not to their
advantage. The reality, however, is that persuasive messages have been widely disseminated for many years,
with the result that few patients are starting from a
neutral position. We believe that it is important to
accept that, in the face of advocacy messages and the
power of anecdotes, persuasive counter-messaging may
be both needed and warranted to convince consumers
to be receptive to evidence and evidence-based recommendations that may run counter to existing beliefs
and help them make more evidence-based choices.
To read or post commentaries in response to this article, see it
online at http://www.annfammed.org/content/15/1/48.
Key words: early detection of cancer; cancer screening; clinical decision
making; mammography; prostate cancer; persuasive interventions
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